Adrenal steroid therapy in neurological disease. Part I.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000818:Animals; D001167:Arteritis / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003095:Collagen Diseases / Q000188:drug therapy; D003882:Dermatomyositis / Q000188:drug therapy; D004660:Encephalitis / Q000188:drug therapy; D004679:Encephalomyelitis / Q000188:drug therapy; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy; D000882:Haplorhini; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D009103:Multiple Sclerosis / Q000188:drug therapy; D009157:Myasthenia Gravis / Q000188:drug therapy; D009220:Myositis / Q000188:drug therapy; D009422:Nervous System Diseases / Q000188:drug therapy*; D009461:Neurologic Manifestations; D010248:Paramethasone / Q000627:therapeutic use; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D011111:Polymyalgia Rheumatica / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy; D012507:Sarcoidosis / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy; D014221:Triamcinolone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D014221:Triamcinolone; D000324:Adrenocorticotropic Hormone; D011241:Prednisone; D010248:Paramethasone